VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Technical Scanner
RSI, Moving averages & volume momentum signals
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
Minervini — VCPContraction bases in Stage 2 uptrends
Minervini — Trend TemplateFull 8-rule Stage 2 screen
O'Neil — Cup with HandleBase breakouts with RS leadership
O'Neil — CANSLIM LeadersGrowth leaders with RS ≥ 85
Qullamaggie — High Tight FlagsPower plays after a large advance
Qullamaggie — Momentum Leaders1/3/6-month strength leaders
Livermore — Pivotal PointsMulti-touch resistance breakouts
View All Playbooks...
Breakouts
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
Breakouts
WatchlistPricing
Ctrl K
Pricing
LUNG
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsCompareWatchlist
LUNGPulmonx Corporation
$2.00$84M
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksLUNGQuarterly Financials

Pulmonx Corporation (LUNG) Quarterly Income Statement

120+ quarters historyFree accessUpdated daily

Pulmonx Corporation (LUNG) quarterly income statement — complete revenue, gross profit & net income history

Income StatementBalance SheetCash FlowRatios

LUNG Income Statement

Quarterly statement

LUNG Income Statement

Pulmonx Corporation (LUNG) annual income statement — 8-year revenue, gross profit & net income history

AnnualQuarterly
MetricQ2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21
Sales/Revenue22.76M20.59M22.6M21.5M23.86M22.54M23.77M20.39M20.78M18.85M19.28M17.67M17.19M14.54M15.43M13.5M13.95M10.79M13.71M13.26M
Revenue Growth %-4.62%-8.66%-4.91%5.47%14.8%19.54%23.28%15.39%20.87%29.71%24.98%30.85%23.25%34.77%12.53%1.82%14.32%16.67%39.45%24.96%
Cost of Goods Sold5.01M4.54M5.06M5.45M6.66M6.2M6.17M5.36M5.48M4.88M4.98M4.64M4.46M3.95M4.24M3.35M3.53M2.67M3.46M3.52M
COGS % of Revenue22.03%22.06%22.38%25.35%27.89%27.49%25.98%26.3%26.35%25.86%25.82%26.26%25.94%27.15%27.49%24.81%25.32%24.79%25.22%26.56%
Gross Profit17.74M16.04M17.54M16.05M17.2M16.34M17.59M15.03M15.31M13.98M14.3M13.03M12.73M10.59M11.18M10.15M10.42M8.11M10.25M9.74M
Gross Margin %77.97%77.94%77.62%74.65%72.11%72.51%74.02%73.7%73.65%74.14%74.18%73.74%74.06%72.85%72.51%75.19%74.68%75.21%74.78%73.44%
Gross Profit Growth %3.13%-1.82%-0.28%6.83%12.39%16.91%23.01%15.33%20.21%32%27.86%28.34%22.23%30.55%9.1%4.24%15.38%22.69%44.83%30.51%
Operating Expenses26.8M29M27.44M30.45M32.01M30.91M31.01M29.16M30.93M28.51M28.22M28.2M29.17M26.99M25.81M24.08M24.83M23.78M22.62M19.5M
OpEx % of Revenue117.77%140.87%121.44%141.59%134.15%137.12%130.47%143.01%148.82%151.24%146.38%159.64%169.67%185.68%167.33%178.37%177.99%220.48%164.99%147.06%
Selling, General & Admin21.77M24.1M22.86M25.6M26.7M26.15M27.01M25.41M25.31M24.3M24.32M23.98M23.46M22.74M21.91M19.72M21.23M20.25M18.91M16.69M
SG&A % of Revenue95.65%117.07%101.16%119.05%111.92%116.02%113.64%124.64%121.8%128.91%126.17%135.75%136.46%156.42%142.03%146.03%152.22%187.71%137.94%125.83%
Research & Development5.03M4.9M4.58M4.85M5.31M4.76M4M3.74M5.62M4.21M3.9M4.22M5.71M4.25M3.9M4.37M3.59M3.53M3.71M2.81M
R&D % of Revenue22.12%23.8%20.28%22.54%22.24%21.1%16.84%18.36%27.02%22.33%20.21%23.89%33.21%29.26%25.3%32.34%25.76%32.77%27.05%21.23%
Other Operating Expenses0000000000000108K000000
Operating Income-9.06M-12.96M-9.9M-14.39M-14.8M-14.56M-13.42M-14.13M-15.62M-14.54M-13.92M-15.18M-16.44M-16.4M-14.63M-13.93M-14.41M-15.67M-12.37M-9.76M
Operating Margin %-39.8%-62.94%-43.82%-66.94%-62.05%-64.62%-56.46%-69.3%-75.17%-77.1%-72.2%-85.9%-95.61%-112.83%-94.83%-103.18%-103.3%-145.28%-90.21%-73.61%
Operating Income Growth %38.82%11.03%26.19%-1.87%5.24%-0.19%3.61%6.9%4.97%11.37%4.84%-8.94%-14.07%-4.67%-18.28%-42.71%-13.63%-25.4%-32.2%-82.54%
EBITDA-8.73M-12.74M-9.67M-14.15M-14.51M-14.03M-13.12M-13.75M-15.22M-14.01M-13.53M-14.76M-16.03M-15.31M-14.24M-13.55M-14.04M-15.3M-11.47M-9.56M
EBITDA Margin %-38.36%-61.87%-42.8%-65.79%-60.79%-62.26%-55.22%-67.46%-73.24%-74.32%-70.19%-83.55%-93.23%-105.33%-92.32%-100.34%-100.61%-141.86%-83.69%-72.06%
EBITDA Growth %39.82%9.24%26.3%-2.86%4.71%-0.14%3.02%6.83%5.04%8.47%4.98%-8.95%-14.21%-0.06%-24.14%-41.77%-11.96%-23.86%-24.34%-82.86%
D&A (Non-Cash Add-back)0220K231K246K299K531K294K376K400K523K387K415K409K1.09M386K383K376K368K894K206K
EBIT-8.73M-12.53M-9.47M-13.02M-14.2M-15.09M-12.29M-13.06M-14.35M-12.68M-12.73M-13.95M-15.19M-15.16M-13.68M-13.89M-14.38M-15.56M-12.65M-9.93M
Net Interest Income-889K-626K-317K-194K-76K83K203K378K415K558K636K597K546K556K389K191K-24K-93K-105K-108K
Interest Income329K350K453K611K723K864K1.04M1.27M1.31M1.44M1.54M1.49M1.41M1.13M748K477K199K105K94K99K
Interest Expense1.22M976K770K805K799K781K842K891K891K883K905K893K864K571K359K286K223K198K199K207K
Other Income/Expense-890K-549K-336K564K-192K250K280K177K380K973K279K335K384K664K590K-241K-189K-93K-488K-375K
Pretax Income-9.95M-13.51M-10.24M-13.83M-15M-14.31M-13.14M-13.95M-15.24M-13.56M-13.64M-14.84M-16.05M-15.74M-14.04M-14.17M-14.6M-15.76M-12.85M-10.14M
Pretax Margin %-43.71%-65.6%-45.31%-64.31%-62.85%-63.51%-55.28%-68.44%-73.34%-71.94%-70.75%-84%-93.38%-108.26%-91%-104.96%-104.66%-146.14%-93.77%-76.44%
Income Tax133K149K186K128K177K135K38K192K84K186K248K59K140K124K246K040K67K152K44K
Effective Tax Rate %-1.34%-1.1%-1.82%-0.93%-1.18%-0.94%-0.29%-1.38%-0.55%-1.37%-1.82%-0.4%-0.87%-0.79%-1.75%0%-0.27%-0.43%-1.18%-0.43%
Net Income-10.08M-13.65M-10.43M-13.96M-15.17M-14.45M-13.18M-14.14M-15.33M-13.75M-13.89M-14.9M-16.2M-15.86M-14.28M-14.17M-14.64M-15.83M-13.01M-10.18M
Net Margin %-44.3%-66.33%-46.13%-64.91%-63.59%-64.11%-55.44%-69.38%-73.74%-72.92%-72.04%-84.33%-94.19%-109.12%-92.6%-104.96%-104.95%-146.76%-94.88%-76.77%
Net Income Growth %33.57%5.5%20.87%1.32%1%-5.08%5.13%5.07%5.37%13.31%2.77%-5.14%-10.62%-0.2%-9.82%-39.2%-12.95%-26.5%-39.89%-163.76%
Net Income (Continuing)-10.08M-13.65M-10.43M-13.96M-15.17M-14.45M-13.18M-14.14M-15.33M-13.75M-13.89M-14.9M-16.2M-15.86M-14.28M-14.17M-14.64M-15.83M-13.01M-10.18M
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)-0.23-0.33-0.25-0.34-0.38-0.36-0.33-0.36-0.39-0.36-0.36-0.39-0.43-0.42-0.38-0.37-0.40-0.43-0.35-0.28
EPS Growth %39.47%8.33%24.24%5.56%2.56%0%8.33%7.69%9.3%14.29%5.26%-5.41%-7.5%2.33%-8.57%-32.14%-17.65%-26.47%-29.63%-154.55%
EPS (Basic)-0.23-0.33-0.25-0.34-0.38-0.36-0.33-0.36-0.39-0.36-0.36-0.39-0.43-0.42-0.38-0.37-0.40-0.43-0.35-0.28
Diluted Shares Outstanding42.18M41.9M41.4M40.94M40.19M39.95M39.11M39.28M38.94M38.64M38.38M38.12M37.82M37.57M37.38M37.19M37M36.81M36.64M36.45M
Basic Shares Outstanding42.18M41.9M41.4M40.94M40.19M39.95M39.11M39.28M38.94M38.64M38.38M38.12M37.82M37.57M37.38M37.19M37M36.81M36.64M36.45M
Dividend Payout Ratio--------------------